TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,079,114 | +533.6% | 263,679 | +543.4% | 0.65% | +477.0% |
| Q2 2023 | $643,780 | +1694057.9% | 40,979 | -24.0% | 0.11% | +2725.0% |
| Q4 2022 | $38 | -99.6% | 53,900 | +4.9% | 0.00% | +300.0% |
| Q3 2022 | $9,000 | -99.7% | 51,400 | -82.6% | 0.00% | -99.4% |
| Q2 2022 | $3,460,000 | +6078.6% | 295,376 | +111.7% | 0.17% | +8600.0% |
| Q1 2022 | $56,000 | -99.5% | 139,500 | -88.5% | 0.00% | -99.3% |
| Q4 2021 | $10,811,000 | +311.5% | 1,214,611 | +45.9% | 0.30% | +248.2% |
| Q3 2021 | $2,627,000 | +9.1% | 832,446 | +2.9% | 0.08% | +13.3% |
| Q2 2021 | $2,407,000 | +449.5% | 808,744 | -24.6% | 0.08% | +476.9% |
| Q4 2020 | $438,000 | -74.5% | 1,072,927 | -0.4% | 0.01% | -86.2% |
| Q2 2020 | $1,720,000 | -20.4% | 1,077,127 | +3.6% | 0.09% | -46.9% |
| Q3 2019 | $2,161,000 | -12.6% | 1,039,527 | -0.3% | 0.18% | -6.8% |
| Q2 2019 | $2,472,000 | +836.4% | 1,042,739 | +36.4% | 0.19% | +726.1% |
| Q1 2019 | $264,000 | – | 764,330 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |